White Paper

HRB probiotics in the HMO era

14 AUG 2024 Wednesday

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Morinaga Milk Industry Co., Ltd., and any views and opinions expressed do not necessarily reflect those of www.nutraingredients-asia.com

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

Download our whitepaper on HRB strains and their compatibility with human milk oligosaccharides (HMOs).

Gain insights into the potential of synbiotic compositions for a healthier gut microbiota.

Latest content from Morinaga Milk Industry Co., Ltd.

Paid for and in partnership with Morinaga Milk Industry Co., Ltd.

Studies show B. breve B-3 can support weight management and healthy ageing

As ageing populations continue to rise and obesity becomes a global concern, how is B. breve B-3 demonstrating beneficial health effects?

Paid for and in partnership with Morinaga Milk Industry Co., Ltd.

Postbiotics: The potential to revolutionize the immune health market

Advancing the conversation around postbiotic quantification and regulation is key for commercial success. ISAPP’s revised definition is helping establish regulatory standards and advance the industry.

Paid for and in partnership with Morinaga Milk Industry Co., Ltd.

Postbiotics: The path to commercialization and success in the market

Postbiotics are emerging as a strong biotic solution but clarification around their definition is an ongoing process. How can postbiotic products achieve market success?